Article Details
Retrieved on: 2025-08-04 20:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Key Takeaways. Roche is advancing trontinemab, a bispecific monoclonal antibody, with Phase III trials for early symptomatic and preclinical ...
Article found on: www.pharmtech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here